Fasting during Ramadan could cause problems for Muslim patients taking prescribed drugs

Fasting from dawn to dusk during Ramadan could cause problems for Muslim patients taking prescribed drugs, warn researchers in this week's BMJ.

During the Islamic holy month of Ramadan, which begins on 15 October 2004, adult Muslims are required to refrain from taking any food, beverages, or oral drugs, between dawn and dusk. Patients with chronic diseases often insist on fasting even though they are permitted not to by Islamic rules.

Several studies have shown that patients arbitrarily modify the times of doses, the number of doses, the time span between doses, and even the total daily dosage of drugs during the month of Ramadan, often without seeking any medical advice.

This behaviour could alter the activity of drugs in the body, leading to therapeutic failures, say the authors. For instance, studies have found delayed absorption, problems with side effects, and drug-food interactions during Ramadan.

They suggest that further studies should be carried out to provide more guidelines about the ways in which the administration of drugs should be modified. In the meantime, doctors and scientists in the Muslim world should be encouraged to follow up their patients with chronic diseases during Ramadan, in order to establish optimal dosage regimens.

Consensus on these issues would allow health professionals to provide accurate and standardised advice on the appropriate use of drugs during the holy month of Ramadan, they conclude.

Click here to view full paper

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diabetes drugs cut asthma attacks by up to 70%, reshaping treatment options